New combinations and immunotherapies for melanoma: latest evidence and clinical utility

by Alexander M. Menzies, Georgina V. Long
Published 2013-09-01

Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors

by Arturas Ziemys, Michelle Kim, Alexander M. Menzies, Alexander M. Menzies, Alexander M. Menzies, James S. Wilmott, Georgina V. Long, Georgina V. Long, Georgina V. Long, Richard A. Scolyer, Richard A. Scolyer, Richard A. Scolyer, Larry Kwong, Ashley Holder, Ashley Holder, Genevieve Boland
Published 2020-05-01

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies

by Hansol Lee, Inês Pires Da Silva, Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long, James S. Wilmott
Published 2021-03-01

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

by Sebastian Hultin, Kazi Nahar, Alexander M. Menzies, Georgina V. Long, Suran L. Fernando, Victoria Atkinson, Jonathan Cebon, Muh Geot Wong
Published 2020-09-01

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

by Ann Livingstone, Kathy Dempsey, Martin R. Stockler, Kirsten Howard, Georgina V. Long, Matteo S. Carlino, Alexander M. Menzies, Rachael L. Morton
Published 2021-09-01

Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition

by John J. Park, Russell J. Diefenbach, Natalie Byrne, Georgina V. Long, Richard A. Scolyer, Elin S. Gray, Matteo S. Carlino, Helen Rizos
Published 2021-04-01

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.

by Alexander M Menzies, Lauren E Haydu, Matteo S Carlino, Mary W F Azer, Peter J A Carr, Richard F Kefford, Georgina V Long
Published 2014-01-01

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma

by Sagun Parakh, Sagun Parakh, Sagun Parakh, Ashan Musafer, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Tom Witkowski, Connie S. N. Li Wai Suen, Candani S. A. Tutuka, Matteo S. Carlino, Matteo S. Carlino, Alexander M. Menzies, Alexander M. Menzies, Richard A. Scolyer, Richard A. Scolyer, Richard A. Scolyer, Jonathan Cebon, Jonathan Cebon, Jonathan Cebon, Alexander Dobrovic, Alexander Dobrovic, Georgina V. Long, Georgina V. Long, Georgina V. Long, Oliver Klein, Oliver Klein, Andreas Behren, Andreas Behren, Andreas Behren
Published 2021-06-01

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

by Andrew Haydon, Shahneen Sandhu, Georgina V Long, Prachi Bhave, Alison Weppler, Matteo S Carlino, Lauren J Brown, Clara Allayous, J. Randall Patrinely Jr, Alexander A Menzies
Published 2021-05-01

Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.

by Andy J Chien, Lauren E Haydu, Travis L Biechele, Rima M Kulikauskas, Helen Rizos, Richard F Kefford, Richard A Scolyer, Randall T Moon, Georgina V Long
Published 2014-01-01

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

by Gulietta M. Pupo, Suzanah C. Boyd, Carina Fung, Matteo S. Carlino, Alexander M. Menzies, Bernadette Pedersen, Peter Johansson, Nicholas K. Hayward, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, Helen Rizos
Published 2017-05-01

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA

by Russell J. Diefenbach, Jenny H. Lee, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Robyn P. M. Saw, Julie R. Howle, Andrew J. Spillane, Richard A. Scolyer, Richard F. Kefford, Helen Rizos
Published 2020-08-01

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients

by Su Yin Lim, Jenny H. Lee, Sarah J. Welsh, Seong Beom Ahn, Edmond Breen, Alamgir Khan, Matteo S. Carlino, Alexander M. Menzies, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, Helen Rizos
Published 2017-11-01

Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

by Tuba N. Gide, Ines P. Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer, James S. Wilmott
Published 2020-01-01

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.

by Kelly J McKelvey, Amanda L Hudson, Ramyashree Prasanna Kumar, James S Wilmott, Grace H Attrill, Georgina V Long, Richard A Scolyer, Stephen J Clarke, Helen R Wheeler, Connie I Diakos, Viive M Howell
Published 2020-01-01

Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets

by Tuba N. Gide, Inês Pires da Silva, Camelia Quek, Peter M. Ferguson, Marcel Batten, Ping Shang, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P. M. Saw, John F. Thompson, Richard A. Scolyer, Georgina V. Long, James S. Wilmott
Published 2021-06-01

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

by Elena Shklovskaya, Jenny H Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter Ferguson, Robyn PM Saw, John F Thompson, Brindha Shivalingam, Matteo S Carlino, Richard A Scolyer, Alexander M Menzies, Georgina V Long, Richard F Kefford, Helen Rizos
Published 2020-11-01

SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling

by Thomas Strub, Flavia G. Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska, Rajendra Singh, Matthew S. Goldberg, Dan Hasson, Zichen Wang, Stuart J. Gallagher, Peter Hersey, Avi Ma’ayan, Georgina V. Long, Richard A. Scolyer, Brian Brown, Bin Zheng, Emily Bernstein
Published 2018-08-01

Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value

by Raymond Barnhill, Pieter‐Jan vanDam, Peter Vermeulen, Gabriel Champenois, André Nicolas, Robert V Rawson, James S Wilmott, John F Thompson, Georgina V Long, Nathalie Cassoux, Sergio Roman‐Roman, Klaus J Busam, Richard A Scolyer, Alexander J Lazar, Claire Lugassy
Published 2020-07-01

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

by Jenny H. Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Y. H. Yang, Dario Strbenac, Robyn P. M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard F. Kefford, Helen Rizos
Published 2020-04-01